Tīmeklis2024. gada 10. janv. · Item 2.02 Results of Operations and Financial Condition The information provided in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.02. The full text of the... December 20, 2024 TīmeklisWe plan to provide updates as EZH-1501 reaches key enrollment milestones and we plan to provide preliminary data from EZH-1501 in the second half of 2024. On March 1, 2024, we announced a pipeline reprioritization. Given the breadth of our current tazemetostat clinical development program, we have discontinued enrollment in our …
Epizyme (EPZM) Q3 Loss Wider Than Expected, Revenues Up
Tīmeklis2024. gada 10. janv. · EZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: The Company recently opened sites for these two basket studies, which … Tīmeklis2024. gada 1. marts · We plan to provide updates on EZH-1501, as it treats key enrollment milestones. We also plan to provide preliminary data from EZH-1501 in the second half of 2024. Additionally, as Grant mentioned ... spritebatch monogame
Epizyme (EPZM) Down More Than 50% in Past 3 Months: Here
Tīmeklis2024. gada 10. nov. · Epizyme received FDA clearance for its IND for EZH-1501, its hematology basket study, which will evaluate tazemetostat safety and efficacy across … TīmeklisEZH-1301 (Solid Tumor) and EZH-1501 (Hematological) Basket Studies: Epizyme recently opened sites for these two basket studies, which sites are actively screening … Tīmeklis2024. gada 10. maijs · Global enrollment open and actively screening in the randomized Phase 3 portion of SYMPHONY-1 (EZH-302): ... We continue to screen patients in … shercon from jungle book